Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    VEC.L Net Margin

    As of 2025-07-03, the Net Margin of Vectura Group PLC (VEC.L) is 64.2%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    VEC.L Net Margin - Historical Value
    DateValue
    2020-12-31 64.2%
    2019-12-31 -12.4%
    2018-12-31 -55%
    2017-12-31 -57.9%
    2016-12-31 -25.4%
    2016-03-31 6.9%
    2015-03-31 6.4%
    2014-03-31 -6.3%
    2013-03-31 -19.3%
    2012-03-31 -13.3%
    VEC.L Net Margin - Peers Comparison
    TickerNameValue
    ACPH.BRAcacia Pharma Group PLC-5781.9%
    AGY.LAllergy Therapeutics PLC-72.9%
    AMYT.LAmryt Pharma PLC-57.2%
    APH.LAlliance Pharma PLC-6%
    CALTX.STCalliditas Therapeutics AB-38.6%
    CAMX.STCamurus AB22.9%
    CLN.WACelon Pharma SA-16.6%
    COPN.SWCosmo Pharmaceuticals NV49.9%
    EAH.LECO Animal Health Group PLC1.2%
    ENZY.STEnzymatica AB (publ)-116.7%
    FAE.MCFaes Farma SA22.6%
    GRD1R.RGGrindeks AS9.5%
    HYL.BRHyloris Pharmaceuticals SA-75%
    INDV.LIndivior PLC0.3%
    IRLAB A.STIRLAB Therapeutics AB-87.8%
    KARO.STKaro Pharma AB-0.6%
    LAVI.ATLavipharm SA17%
    MARI.VIMarinomed Biotech AG-74%
    MITRA.BRMithra Pharmaceuticals SA-432.1%
    OLF1R.RGOlainfarm AS7.8%
    ORX.STOrexo AB-34.4%
    PHO.OLPhotocure ASA-0.6%
    RJF.MCLaboratorio Reig Jofre SA3.1%
    SECARE.STSwedencare AB (publ)3.9%
    SHE.MIShedir Pharma Srl Unipersonale9.6%
    VETO.PAVetoquinol SA10.9%
    VISTN.OLVistin Pharma ASA14.6%
    Tickers added to watchlist